Breast cancer is biologically heterogeneous, comprising subtypes such as Luminal A, Luminal B, HER2-enriched, and triple-negative, each with distinct prognoses and therapeutic responses [4]. The gene discussed is ERBB2; the disease is breast carcinoma.